Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 51, Issue 12

Issues

More discussion on journal impact factor

Eleftherios P. Diamandis
  • Corresponding author
  • Hold’em for Life Chair in Prostate Cancer Biomarkers, Division Head of Clinical Biochemistry, Mount Sinai Hospital and University Health Network, Professor & Head, Division of Clinical Biochemistry, Department of Laboratory Medicine & Pathobiology, University of Toronto, Mount Sinai Hospital, Joseph & Wolf Lebovic Ctr., 60 Murray St [Box 32], Flr 6 – Rm L6–201 Toronto, ON, M5T 3L9, Canada
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2013-08-02 | DOI: https://doi.org/10.1515/cclm-2013-0515

In 2009, Clinical Chemistry and Laboratory Medicine published two ‘opinion’ papers, one by myself [1] and another one by Favaloro [2], debating the usefulness and longevity of the journal impact factor. At that time, I predicted that journal impact factor will fade away soon, while Dr. Favaloro expressed a different, opposing opinion.

Recently, during the 2012 American Society for Cell Biology meeting, the usefulness of the journal impact factor has been debated [3]. These deliberations led to the preparation of a document known as The San Francisco Declaration of Research Assessment (DORA), which has been sponsored/signed by more than 150 leading scientists and 75 scientific organizations. DORA stipulates that the journal impact factor must not be used as a surrogate measure of the quality of individual research articles, to assess an individual scientist’s contributions, or used in hiring, promotion and funding decisions. The declaration further recommends alternative metrics for evaluating researchers, including citation counts of individual articles. Essentially, these recommendations endorse the central message of my previous editorial [1], which states that the impact of an individual paper is not necessarily related to the impact factor of the journal that published it.

I believe that the readers of Clinical Chemistry and Laboratory Medicine who have read the previous commentaries on journal impact factor [1, 2], should be interested to look at these latest recommendations (www.ascb.org/SFdeclaration.html).

Conflict of interest statement

Authors’ conflict of interest disclosure: The authors stated that there are no conflicts of interest regarding the publication of this article.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

References

About the article

Corresponding author: Eleftherios P. Diamandis, MD, PhD, FRCP(C), FRSC, Hold’em for Life Chair in Prostate Cancer Biomarkers, Division Head of Clinical Biochemistry, Mount Sinai Hospital and University Health Network, Professor & Head, Division of Clinical Biochemistry, Department of Laboratory Medicine & Pathobiology, University of Toronto, Mount Sinai Hospital, Joseph & Wolf Lebovic Ctr., 60 Murray St [Box 32], Flr 6 – Rm L6–201 Toronto, ON, M5T 3L9, Canada, E-mail:


Received: 2013-07-08

Accepted: 2013-07-10

Published Online: 2013-08-02

Published in Print: 2013-12-01


Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 51, Issue 12, Pages 2271–2271, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2013-0515.

Export Citation

©2013 by Walter de Gruyter Berlin Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Clare Fiala and Eleftherios P. Diamandis
Clinical Biochemistry, 2019
[2]
Clare Fiala and Eleftherios P. Diamandis
Clinical Biochemistry, 2017, Volume 50, Number 12, Page 651
[3]
Eleftherios P. Diamandis
Clinical Biochemistry, 2017, Volume 50, Number 9, Page 461
[4]
Eleftherios P. Diamandis
BMC Medicine, 2017, Volume 15, Number 1
[5]
Giuseppe Lippi and Loris Borghi
Clinical Chemistry and Laboratory Medicine (CCLM), 2014, Volume 52, Number 2

Comments (0)

Please log in or register to comment.
Log in